The University of California hospital system may be the cause of two deaths as of Feb 19. Patients who received endoscopic treaments may have been exposed to carbapenem-resistant Enterobacteriaceae, or CRE, “which kill up to half the patients who contract them.” According to CNN.
“The 179 patients who may have been infected by CRE, are being offered home testing kits” According to Reuters.com. In recent years, hospitals across the nation have reported exposures from the same equipment. The FDA responded with attempts to address the situation.
“UCLA spokeswoman Roxanne Moster said both scopes in question, which the hospital started using in June 2014, had been permanently set aside and would be returned to the manufacturer.” Reuters reports.
Superbugs contribute to over 2 million illnesses each year in the U.S. This case is still being investigated.